Latest stories, analysis, and insights from the world of health.
Eli Lilly has released Phase 1 trial data for VERV-102, a gene editing therapeutic designed to reduce cholesterol levels by targeting specific genetic pathways. The preliminary results represent a significant step forward in developing gene-based treatments for cardiovascular disease.
A new study reveals a dramatic rise in fake references in biomedical research, with fabricated citations increasing 12-fold since 2023, reaching a rate of one in 277 papers by early 2026, raising serious concerns about AI-generated misinformation in scientific literature.
Eli Lilly's experimental gene-editing therapy demonstrates early efficacy in Phase 1 trials for cholesterol management, marking a significant advancement in genetic treatment approaches.
Eli Lilly announced that its gene-editing therapy VERV-102 reduced LDL cholesterol by 62% in Phase 1 clinical trial participants, with no serious adverse events reported. The therapy, acquired in a $1 billion buyout of Verve Therapeutics, could offer a one-time treatment option for patients struggling with conventional cholesterol-lowering medications.
Experts warn that the perimenopause awareness movement is fueling misinformation, portraying women as slaves to their hormones, and driving a booming industry selling unproven supplements and treatments, while potentially causing women to overlook more serious health conditions.
The WHO has elevated the public health risk from the Ebola outbreak in the Democratic Republic of Congo from "high" to "very high," with nearly 750 suspected cases and 177 deaths reported so far from the rare Bundibugyo species.
An Ebola outbreak in the Democratic Republic of Congo has infected over 867 suspected cases and killed 204 people, with cases now spreading to neighboring Uganda. Health workers face major obstacles including community distrust, armed conflict, and a rare virus strain in remote mining regions.
A devastating measles outbreak in Bangladesh has killed over 500 children and sickened more than 60,000 since March 2026, largely due to vaccination campaign delays under the interim government and widespread childhood malnutrition.
RaDonda Vaught, convicted of negligent homicide after a fatal medication error at Vanderbilt Medical Center, has become a sought-after speaker sharing her cautionary tale to improve hospital safety systems in an era of automation and artificial intelligence.
Attacks on Ebola health facilities in eastern Democratic Republic of Congo are intensifying as tensions grow over burial protocols and cultural traditions clash with medical response efforts. The outbreak has claimed nearly 180 lives with close to 800 cases recorded, while mistrust and misinformation drive violence against treatment centres.
Two experts argue that the surge in perimenopause awareness is medicinalizing a natural life transition, blaming women's symptoms on hormones rather than aging or stress, while fueling a profitable industry of unproven supplements and treatments.
The World Health Organization has raised the public health risk from the Ebola outbreak in the Democratic Republic of Congo from "high" to "very high," with nearly 750 suspected cases and 177 suspected deaths reported. Scientists are developing new vaccines that could enter clinical trials within months.
Social media influencers and supplement companies are spreading misleading health claims about perimenopause treatments, prompting health experts to address dangerous misinformation about hormones and wellness products.
The World Health Organization has raised the public health risk from the Ebola outbreak in the Democratic Republic of Congo from "high" to "very high," with nearly 750 suspected cases and 177 suspected deaths from the rare Bundibugyo species.
Two medical experts argue that the surge in perimenopause awareness is fueling misinformation, portraying women as slaves to their hormones while selling them unproven products and supplements.
<UNKNOWN>
Mass General Brigham executives claim the health system has saved over 1,400 more lives through streamlined quality metrics and improved mortality ratios, but many doctors skeptically question whether the improvements result from actual clinical changes or administrative data adjustments like increased hospice enrollment and better clinical coding.
Biogen and Denali Therapeutics announced that their experimental LRRK2-targeting therapy failed to slow Parkinson's disease in a randomized trial of 648 patients, dealing a significant setback to the scientific approach and the patient community.
Melanoma skin cancer cases in the UK have exceeded 20,000 annually for the first time, with Cancer Research UK warning that nine in ten cases are preventable through sun safety measures.
Robert F. Kennedy Jr. issues a warning about excessive screen time and its potential health impacts.